Past Events

Midwest Melanoma and High Risk Skin Cancer Symposium

Aired on 7.16.2021
FREE
Midwest Melanoma and High Risk Skin Cancer Symposium CME

Midwest Melanoma and High Risk Skin Cancer Symposium 

July 16, 2021, 8:00 am - 1:15 pm EST

 

 

 

Description

About the Course

This half day CME accredited symposium is specifically designed to provide those who have skin cancer management interests the latest advances in prevention, surveillance, and local-regional and systemic therapies.

This activity will bring together an audience of medical oncologists, radiation oncologists, surgeons, dermatologists, nurses, and other health care providers to discuss management of these patients.

Faculty

Faculty

Joshua Arbesman, MD

Steven Billings, MD

Samuel Chao, MD

Pauline Funchain, MD

Brian Gastman, MD

Jessica Geiger, MD

Pedram Gerami, MD

Thomas Knackstedt, MD

Jennifer Ko, MD

Shlomo Koyfman, MD

Ankit Mangla, MD

Shira Ronen, MD

Chrysalyne D Schmults, MD

Vernon Sondak, MD

Kavita Vakharia, MD

Allison Vidimos, MD

Alok Vij, MD

Jeffrey S Weber, MD

Agenda

8:00 am - 8:05 am
Welcome/Introduction
8:05 am - 8:45 am
Work Up of Difficult to Diagnose Pigmented Lesions



8:45 am - 9:10 am
State of Adjuvant Testing to Make the Diagnosis of Melanoma
9:10 am - 9:50 am
Break Out Session 1: Treatment of Brain Metastases and the Role of Clincial Trials



9:10 am - 9:50 am
Break Out Session 2: Dermatologic Follow-up of Patients with Recent Diagnosis of High Risk Skin Cancer



9:50 am - 10:30 am
Controversies in High Risk Local and Locoregional Melanoma




10:30 am - 10:55 am
Lessons Learned from Adjuvant Therapy Trials
10:55 am - 11:15 am
Break/Exhibit Hall
11:15 am - 11:40 am
Emergence of Neoadjuvant Therapy in Melanoma
11:40 am - 12:20 pm
Break Out Session 3: Controversies in Mohs





11:40 am - 12:20 pm
Break Out Session 4: Systemic Standard of Care Treatment Failure, Now What?




12:20 pm - 12:45 pm
Staging in cSCC
12:45 pm - 1:10 pm
Controversies in the Treatment of cSCC





1:10 pm - 1:15 pm
Adjourn

Objectives

Learning Objectives

Following participation in this course the participant will be able to:

  1. Recognize best standards in preventing and diagnosing melanoma.
  2. Discuss treatment options for high risk primary and locoregional metastatic melanoma.
  3. Identify options for patients with refractory melanoma.
  4. Describe emerging management options for cutaneous squamous cell carcinoma.

Disclosures and Accreditation Statement

Faculty Disclosure

The Cleveland Clinic Foundation Center for Continuing Education has implemented a policy to comply with the current Accreditation Council for Continuing Medical Education Standards for Commercial Support requiring resolution of all faculty conflicts of interest. Faculty declaring a relevant commercial interest will be identified in the activity syllabus.

Accreditation

The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Cleveland Clinic Foundation Center for Continuing Education designates this live activity for a maximum of 4.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.

The Ohio Board of Nursing will accept at face value the number of contact hours awarded for an educational activity that has been approved for CE by a nationally accredited system of CE approval.

Nurses are able to obtain CE that has been approved or provided by a nationally recognized accreditation system of continuing education.

Examples include:

  • The American Nurses Credentialing Center (ANCC)
  • The Accreditation Council for Continuing Medical Education (ACCME)
  • The International Association for Continuing Education and Training (IACET)